Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key.
作者信息
Yu Jiangquan, Zheng Ruiqiang, Qiu Haibo
机构信息
Department of Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu Province, China.
Department of Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu Province, China.
出版信息
J Transl Int Med. 2021 Jul 9;9(2):68-70. doi: 10.2478/jtim-2021-0029. eCollection 2021 Jun.
Abstract
摘要
相似文献
1
Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key.
J Transl Int Med. 2021 Jul 9;9(2):68-70. doi: 10.2478/jtim-2021-0029. eCollection 2021 Jun.
2
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial.
Crit Care Med. 2021 Jul 1;49(7):1015-1025. doi: 10.1097/CCM.0000000000005066.
3
Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series.
Crit Care Explor. 2020 Oct 1;2(10):e0237. doi: 10.1097/CCE.0000000000000237. eCollection 2020 Oct.
4
Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series.
J Med Case Rep. 2021 Nov 23;15(1):564. doi: 10.1186/s13256-021-03059-y.
5
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Clin Microbiol Infect. 2020 Oct;26(10):1436-1446. doi: 10.1016/j.cmi.2020.08.005. Epub 2020 Aug 11.
6
Convalescent plasma for people with COVID-19: a living systematic review.
Cochrane Database Syst Rev. 2023 Feb 1;2(2):CD013600. doi: 10.1002/14651858.CD013600.pub5.
7
Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment.
mBio. 2023 Feb 28;14(1):e0328722. doi: 10.1128/mbio.03287-22. Epub 2023 Jan 10.
8
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
mBio. 2020 Oct 16;11(5):e02590-20. doi: 10.1128/mBio.02590-20.
9
Analysis of Convalescent Plasma Transfusion in Children Confirmed with COVID-19: A Systemic Review.
Florence Nightingale J Nurs. 2022 Oct;30(3):301-309. doi: 10.5152/FNJN.2022.21260.
10
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Cochrane Database Syst Rev. 2021 May 20;5(5):CD013600. doi: 10.1002/14651858.CD013600.pub4.
引用本文的文献
1
Effect of convalescent plasma therapy on mortality in moderate-to-severely Ill COVID-19 patients.
Transfus Apher Sci. 2022 Dec;61(6):103455. doi: 10.1016/j.transci.2022.103455. Epub 2022 May 11.
本文引用的文献
1
Convalescent plasma to treat COVID-19: clinical experience and efficacy.
Aging (Albany NY). 2021 Mar 18;13(6):7758-7766. doi: 10.18632/aging.202795.
2
Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes.
Hum Immunol. 2021 Apr;82(4):255-263. doi: 10.1016/j.humimm.2021.02.007. Epub 2021 Feb 16.
3
COVID-19 convalescent plasma: Interim recommendations from the AABB.
Transfusion. 2021 Apr;61(4):1313-1323. doi: 10.1111/trf.16328. Epub 2021 Mar 7.
4
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
N Engl J Med. 2021 Mar 18;384(11):1015-1027. doi: 10.1056/NEJMoa2031893. Epub 2021 Jan 13.
5
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.
Nat Med. 2020 Nov;26(11):1708-1713. doi: 10.1038/s41591-020-1088-9. Epub 2020 Sep 15.
6
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality.
Am J Pathol. 2020 Nov;190(11):2290-2303. doi: 10.1016/j.ajpath.2020.08.001. Epub 2020 Aug 11.
7
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
JAMA. 2020 Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044.
8
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma.
Am J Pathol. 2020 Aug;190(8):1680-1690. doi: 10.1016/j.ajpath.2020.05.014. Epub 2020 May 27.
9
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol.
Intern Emerg Med. 2020 Aug;15(5):819-824. doi: 10.1007/s11739-020-02384-2. Epub 2020 May 28.
10
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600.
Zotero 插件